News About: Pharm. Industry
Handok Pharm sets standard in industrial peaceHandok Pharm sets a new standard to make good relations between management and unions.
The company has been maintaining industrial peace, with no labor disputes since 1998.
...
|
Clinically effective generic drug price to fall by 10 percent
When a generic drug with clinical effectiveness gets listed for insurance coverage, its price will be decreased by 10 percent over that of the corresponding original drug, the Ministry for Health, Welfare and Family A...
Wyeth Korea union regrets labor commission’s award
The union members of Wyeth Korea have recently expressed strong regret over the Seoul Regional Labor Relation Commission's rejection of its appeal to correct management’s unfair labor treatment.
The union said it w...
Berna Biotech wins $100 million export tower at Trade DayBerna Biotech Korea, an affiliated company of Dutch biopharma company Crucell, won the $100 million export prize for its role to boost the nation’s export at the 45th Trade Day....
|
Pfizer Korea to recruit CRAs and CTAs
Pfizer Korea will recruit several clinical research associates (CRAs) and clinical trial assistants (CTAs) through its global human resources recruitment program in December.
University graduates and those who are ...
Labor commission rejects Wyeth union’s appeal
The Seoul Regional Labor Relation Commission rejected again the appeal by Wyeth Korea’s union on December 1, saying management was not involved in any unfair labor activities that had been a hot potato between union l...
Pharmaceutical firms moving against Kyungdong Pharm
A number of pharmaceutical companies, including GlaxoSmithKoline, decided to reject the supply of pharmaceuticals to Kyundong Pharm, which was acquired by RMS Korea.
There is general consensus that RMS Korea owned ...
Novartis Korea CEO elected KRPIA headThe Korean-based Pharmaceutical Industry Association (KRPIA) said on December 2 that it appointed Peter Jager, chief executive of Novartis Korea, as its new president.
Jager...
|
LG Life Sciences wins $100 million export tower
LG Life Sciences (LGLS) won the nation’s “Tower of $100 million Export’’ prize for the first time as a pharmaceutical firm.
In the 45th Trade day on December 2, LGCS said its pharmaceutical export posted $120 milli...
Enbrel gears up share
Wyeth’s Enbrel generated the strongest growth in the domestic rheumatoid arthritis market.
Enbrel is the only soluble tumor necrosis factor (TNF) receptor approved to reduce signs and symptoms, induce major clinic...
